Drew Moghanaki 🐕(@DrewMoghanaki) 's Twitter Profileg
Drew Moghanaki 🐕

@DrewMoghanaki

MD, MPH - Lung Cancer Specialist and Professor, David Geffen School of Medicine at UCLA | Co-Director, Lung Precision Oncology Program, VA Greater Los Angeles

ID:1322269645

linkhttps://www.uclahealth.org/radonc/drew-moghanaki calendar_today02-04-2013 11:09:53

22,2K Tweets

10,8K Followers

1,3K Following

Drew Moghanaki 🐕(@DrewMoghanaki) 's Twitter Profile Photo

Elevator selfies are the best, especially when you’re standing next to the super nice, smart, and fun Nancy Lee! mskcc.org/cancer-care/do…

Elevator selfies are the best, especially when you’re standing next to the super nice, smart, and fun Nancy Lee! #RANZCR22 #radonc mskcc.org/cancer-care/do…
account_circle
Drew Moghanaki 🐕(@DrewMoghanaki) 's Twitter Profile Photo

Hey Gerry Hanna 💙, we really miss you and wish you could be with us. A lot of folks have shared that meetings just aren’t the same without you!

Hey @gerryhanna, we really miss you and wish you could be with us. A lot of folks have shared that #RANZCR meetings just aren’t the same without you! #radonc
account_circle
Drew Moghanaki 🐕(@DrewMoghanaki) 's Twitter Profile Photo

Here’s a photo of the Australian Bragg Centre in Adelaide (taken today), and a link to learn about William Henry Bragg’s relationship with the Uni of Adelaide. adelaide.edu.au/library/specia…

Here’s a photo of the Australian Bragg Centre in Adelaide (taken today), and a link to learn about William Henry Bragg’s relationship with the @UniofAdelaide. #radonc adelaide.edu.au/library/specia…
account_circle
Neha Vapiwala(@NehaVapiwala) 's Twitter Profile Photo

Is that really me standing between 2 visionaries & co-creators of @ASTRO’s new HEDI Council? Not to mention 2 of the FINEST people I’ve ever met…and seen, for that matter 😉

Is that really me standing between 2 visionaries & co-creators of @ASTRO’s new HEDI Council? Not to mention 2 of the FINEST people I’ve ever met…and seen, for that matter 😉 #ASTRO22 #DEIinRO
account_circle
Clayton P. Smith, MD(@claysmithmd) 's Twitter Profile Photo

Awesome talk by UCLA Health co-resident Martin Ma at titled, ‘Sequencing of Androgen Deprivation Therapy of Short Duration with Radiotherapy for Non-Metastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.’

Awesome talk by @UCLAHealth co-resident @MartinMaMDPhD at #ASTRO22 titled, ‘Sequencing of Androgen Deprivation Therapy of Short Duration with Radiotherapy for Non-Metastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.’
account_circle
Drew Moghanaki 🐕(@DrewMoghanaki) 's Twitter Profile Photo

Phase III MIRAGE will push us to rethink how much PRO acute toxicity matters (EPIC-26). We’ve been measuring it for decades, so I assume all care. Our patients certainly do. Martin Sanda MD Stephen Freedland, MD

account_circle
Drew Moghanaki 🐕(@DrewMoghanaki) 's Twitter Profile Photo

Once again, scientific inquiry demonstrates surgical resection of malignant tumors is unlikely to help all operable patients live longer when outpatient radiation therapy is an option.

account_circle
Shankar Siva(@_ShankarSiva) 's Twitter Profile Photo

Late breaking - LUSTRE phase III N=233, randomised SABR vs conventional in median F/U 3.1 yrs. BOTH central and peripheral tumours. Closed earlier than expected, no statistical diff between arms. So close!! 🫣 OncoAlert

Late breaking #ASTRO22 - LUSTRE phase III N=233, randomised SABR vs conventional #radiotherapy in #lungcancer median F/U 3.1 yrs. BOTH central and peripheral tumours. Closed earlier than expected, no statistical diff between arms. So close!! 🫣 @OncoAlert #radonc #lcsm
account_circle
Shankar Siva(@_ShankarSiva) 's Twitter Profile Photo

Trimodality bladder preservation versus cystectomy for muscle invasive bladder cancer; matched cohort OncoAlert. Dr J Efstathiou - outcomes similar for TMT versus cystectomy. 13% required salvage cystectomy, but did not impact survival. Hydronephrosis a bad player ☹️

Trimodality bladder preservation versus cystectomy for muscle invasive bladder cancer; matched cohort #ASTRO22 @OncoAlert. Dr J Efstathiou - outcomes similar for TMT versus cystectomy. 13% required salvage cystectomy, but did not impact survival. Hydronephrosis a bad player ☹️
account_circle